应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02269 药明生物
已收盘 08-28 16:08:33
50.650
+0.150
+0.30%
最高
52.000
最低
50.100
成交量
3,303万
今开
50.500
昨收
50.500
日振幅
3.76%
总市值
2,099亿
流通市值
2,099亿
总股本
41.45亿
成交额
16.78亿
换手率
0.80%
流通股本
41.45亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中金:药明生物(02269.HK)盈利能力改善 升目标价25%至60港元兼上调盈测
智通财经 · 16:23
中金:药明生物(02269.HK)盈利能力改善 升目标价25%至60港元兼上调盈测
招银国际:上调药明生物(02269)目标价至60港元 维持“买入”评级
智通财经 · 10:29
招银国际:上调药明生物(02269)目标价至60港元 维持“买入”评级
大行评级丨大和:上调药明生物目标价至59港元,重申“买入”评级
格隆汇 · 08-27 15:20
大行评级丨大和:上调药明生物目标价至59港元,重申“买入”评级
高盛:升药明生物(02269.HK)上半年收入及盈利胜预期 上调2026至2028年盈测
智通财经 · 08-27 15:07
高盛:升药明生物(02269.HK)上半年收入及盈利胜预期 上调2026至2028年盈测
大和:药明生物(02269.HK)上半年业绩受惠毛利率优于预期 升目标价至59港元
智通财经 · 08-27 14:46
大和:药明生物(02269.HK)上半年业绩受惠毛利率优于预期 升目标价至59港元
异动解读|药明生物盘中下跌3.05%,中期业绩兑现后CXO板块集体回调
行情直击 · 08-27 10:31
异动解读|药明生物盘中下跌3.05%,中期业绩兑现后CXO板块集体回调
【券商聚焦】国投证券:创新药有望开启新一轮高景气周期
金吾财讯 · 08-27 09:29
【券商聚焦】国投证券:创新药有望开启新一轮高景气周期
药明生物上半年营收118亿:同比增18% 净利29亿 市值2110亿港元
雷递网 · 08-26 15:11
药明生物上半年营收118亿:同比增18% 净利29亿 市值2110亿港元
大行评级丨大摩:药明生物上半年业绩胜预期,目标价升至57港元
格隆汇 · 08-26 10:42
大行评级丨大摩:药明生物上半年业绩胜预期,目标价升至57港元
异动解读|药明生物盘中上涨4.02%,中期业绩强劲叠加上调全年业绩指引
行情直击 · 08-26 09:30
异动解读|药明生物盘中上涨4.02%,中期业绩强劲叠加上调全年业绩指引
药明生物(02269.HK)上调全年业绩指引,持续高速增长
智通财经 · 08-25 20:09
药明生物(02269.HK)上调全年业绩指引,持续高速增长
药明生物(02269)披露2026年中期业绩:收入53.8亿元,同比增24.9%
公告速递 · 08-25 19:56
药明生物(02269)披露2026年中期业绩:收入53.8亿元,同比增24.9%
药明生物中期净利达24.398亿元人民币
投资观察 · 08-25 18:06
药明生物中期净利达24.398亿元人民币
药明生物(02269.HK)2026中期业绩强劲:收益118亿元,经调整归母净利同比增长38.4%
智通财经 · 08-25 17:59
药明生物(02269.HK)2026中期业绩强劲:收益118亿元,经调整归母净利同比增长38.4%
药明生物(02269)发布中期业绩 公司拥有人应占纯利24.4亿元 同比增长4.3%
智通财经网 · 08-25 17:58
药明生物(02269)发布中期业绩 公司拥有人应占纯利24.4亿元 同比增长4.3%
药明生物:上半年收益达117.87亿元,同比增长18.4%
老虎资讯综合 · 08-25 17:58
药明生物:上半年收益达117.87亿元,同比增长18.4%
药明生物(02269)2026年中期营收增18.4%至117.87亿元 净利29.16亿元同比增5.8%
公告速递 · 08-25 17:56
药明生物(02269)2026年中期营收增18.4%至117.87亿元 净利29.16亿元同比增5.8%
港股收评:恒指午后逆转跌幅几近收平,PCB与创新药爆发,黄金股全面回调
格隆汇 · 08-25
港股收评:恒指午后逆转跌幅几近收平,PCB与创新药爆发,黄金股全面回调
港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认
智通财经 · 08-25
港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认
港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认
智通财经 · 08-25
港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认
加载更多
公司概况
公司名称:
药明生物
所属市场:
SEHK
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":50.65,"timestamp":1787904513006,"preClose":50.5,"halted":0,"volume":33034912,"delay":0,"changeRate":0.002970297029702942,"floatShares":4145000000,"shares":4145000000,"eps":1.3539258916215222,"marketStatus":"已收盘","change":0.15,"latestTime":"08-28 16:08:33","open":50.5,"high":52,"low":50.1,"amount":1678230845,"amplitude":0.037624,"askPrice":50.65,"askSize":117500,"bidPrice":50.6,"bidSize":42000,"shortable":3,"etf":0,"ttmEps":1.3816638015961993,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":50.5,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0.588936,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.4309,"impliedVolPercentile":0.1551},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2662050514","title":"中金:药明生物(02269.HK)盈利能力改善 升目标价25%至60港元兼上调盈测","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662050514?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:23","pubTimestamp":1787905398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0181495838.USD","LU0456827905.SGD","LU0856984785.SGD","LU3063872942.SGD","LU0417516902.SGD","LU1720050803.USD","LU0516422952.EUR","LU0516423174.USD","LU0140636845.USD","LU0516423091.SGD","IE00B0JY6N72.USD","LU1880383366.USD","LU0128526141.USD","LU0359201612.USD","LU1794554557.SGD","LU1688375341.USD","BK1589","SG9999002463.SGD","LU0516422440.USD","LU0043850808.USD","LU0326950275.SGD","KURE","LU0516422366.SGD","LU0039217434.USD","LU0327786744.USD","LU1242518931.SGD","LU2039709279.SGD","BK1610","LU0348735423.USD","LU0051755006.USD","LU0456846285.SGD","BK1141","LU0359202008.SGD","02269","LU0052750758.USD","LU1242518857.USD","LU0588546209.SGD","LU0823426480.USD","LU0029874061.USD","LU0708995583.HKD","LU0979878070.USD","LU0572944931.SGD","LU0417516738.SGD","LU0823426308.USD","BK1576","BK1521","LU0819121731.USD","LU0307460666.USD","SG9999002562.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058628","title":"招银国际:上调药明生物(02269)目标价至60港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662058628?lang=zh_cn&edition=full","pubTime":"2026-08-28 10:29","pubTimestamp":1787884160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,招银国际发布研报称,药明生物(02269)上半年业绩强劲,全年收入增长指引亦上调至15%-18%,将药明生物目标价由39港元上调至60港元,维持“买入”评级。该行上调药明生物业绩预测,预计2026年收入同比增长17.1%,经调整净利润同比增长16.5%,以反映上调的业绩指引及积极的板块需求展望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02269","PRTO","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776197","title":"大行评级丨大和:上调药明生物目标价至59港元,重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776197","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662776197?lang=zh_cn&edition=full","pubTime":"2026-08-27 15:20","pubTimestamp":1787815225,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0051755006.USD","LU0140636845.USD","LU0572944931.SGD","LU0326950275.SGD","02269","LU0128526141.USD","LU1242518931.SGD","LU0516422952.EUR","LU0359202008.SGD","LU0307460666.USD","SG9999002463.SGD","LU0417516738.SGD","LU0823426308.USD","LU0052750758.USD","LU0456846285.SGD","BK1589","LU1720050803.USD","BK1576","LU0348825331.USD","LU0417516902.SGD","LU1880383366.USD","LU1688375341.USD","LU1794554557.SGD","LU0327786744.USD","LU0348735423.USD","LU0588546209.SGD","LU0856984785.SGD","LU0029874061.USD","LU0823426480.USD","LU3063872942.SGD","IE00B0JY6N72.USD","SG9999002562.SGD","LU0516423174.USD","KURE","BK1521","LU1242518857.USD","LU0819121731.USD","LU0181495838.USD","LU0516422366.SGD","LU0516423091.SGD","LU0039217434.USD","BK1141","LU0043850808.USD","LU2039709279.SGD","LU0979878070.USD","LU0516422440.USD","LU0456827905.SGD","LU0708995583.HKD","LU0359201612.USD","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662177915","title":"高盛:升药明生物(02269.HK)上半年收入及盈利胜预期 上调2026至2028年盈测","url":"https://stock-news.laohu8.com/highlight/detail?id=2662177915","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662177915?lang=zh_cn&edition=full","pubTime":"2026-08-27 15:07","pubTimestamp":1787814423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0456846285.SGD","LU0856984785.SGD","LU0052750758.USD","LU0823426308.USD","SG9999002562.SGD","LU0588546209.SGD","BK1576","LU0417516738.SGD","BK1589","LU0516423174.USD","LU0348825331.USD","LU0181495838.USD","LU0516422440.USD","LU1688375341.USD","LU0140636845.USD","LU0359202008.SGD","KURE","SG9999002463.SGD","LU1242518931.SGD","LU0819121731.USD","BK1141","LU0128526141.USD","LU0039217434.USD","LU1242518857.USD","LU0327786744.USD","LU0516423091.SGD","LU0979878070.USD","BK1521","LU0043850808.USD","LU1720050803.USD","LU3063872942.SGD","LU2039709279.SGD","LU0307460666.USD","LU0029874061.USD","02269","LU0516422366.SGD","LU0708995583.HKD","LU1794554557.SGD","LU1880383366.USD","LU0348735423.USD","LU0326950275.SGD","LU0516422952.EUR","LU0823426480.USD","BK1610","LU0359201612.USD","LU0320764599.SGD","LU0572944931.SGD","LU0417516902.SGD","IE00B0JY6N72.USD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776874","title":"大和:药明生物(02269.HK)上半年业绩受惠毛利率优于预期 升目标价至59港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776874","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662776874?lang=zh_cn&edition=full","pubTime":"2026-08-27 14:46","pubTimestamp":1787813182,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1589","KURE","LU0051755006.USD","LU0320764599.SGD","LU0516423091.SGD","LU0708995583.HKD","LU0856984785.SGD","BK1576","LU0516422440.USD","LU1880383366.USD","02269","LU0043850808.USD","LU0456827905.SGD","LU0307460666.USD","LU0348735423.USD","BK1521","BK1610","LU0819121731.USD","LU0823426480.USD","LU0516422952.EUR","IE00B0JY6N72.USD","LU0979878070.USD","LU0052750758.USD","BK1141","LU0588546209.SGD","LU0181495838.USD","LU0417516902.SGD","LU2039709279.SGD","LU0417516738.SGD","LU0456846285.SGD","LU1242518931.SGD","LU3063872942.SGD","LU0140636845.USD","LU0572944931.SGD","LU1720050803.USD","SG9999002562.SGD","LU0029874061.USD","LU1794554557.SGD","LU0039217434.USD","LU0359202008.SGD","LU0359201612.USD","LU0128526141.USD","LU1242518857.USD","LU1688375341.USD","LU0327786744.USD","LU0516423174.USD","SG9999002463.SGD","LU0326950275.SGD","LU0516422366.SGD","LU0823426308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190830011","title":"异动解读|药明生物盘中下跌3.05%,中期业绩兑现后CXO板块集体回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1190830011","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190830011?lang=zh_cn&edition=full","pubTime":"2026-08-27 10:31","pubTimestamp":1787797884,"startTime":"0","endTime":"0","summary":"8月27日,药明生物盘中下跌3.05%,报49.2港元,成交额10.37亿港元。消息面上,公司此前于8月25日发布强劲中期业绩并上调全年指引,股价连续两日大涨,短期累积涨幅较大,部分资金选择获利了结。今日CXO板块整体走弱,同行业康龙化成跌5.24%、药明合联跌5.11%、金斯瑞生物科技跌4.41%、药明康德跌1.05%,板块呈现集体回调态势。此前多家投行上调药明生物目标价,基本面预期已充分反映,短期获利盘压力有所释放。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明生物盘中下跌,CXO板块集体回调","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729977","title":"【券商聚焦】国投证券:创新药有望开启新一轮高景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729977","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662729977?lang=zh_cn&edition=full","pubTime":"2026-08-27 09:29","pubTimestamp":1787794154,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国投证券研究指,医药景气新周期背景下,国内创新药产业链加速崛起。近年国家多举措全链条支持创新药发展,叠加国内得天独厚的人才储备和研发效率等多维优势,国内创新药持续加速崛起且逐步具备全球竞争力。与此同时,海外MNC陆续面临专利悬崖困境,对外采购和扩充创新管线需求与日俱增,国内创新药企顺势而为,以海外授权BD等形式实现创新出海,创新药有望开启新一轮高景气周期。风险提示:产品研发及审批速度低于预期;产品降价超预期风险;海外BD授权不及预期风险;计算及假设不及预期风险。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989630","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","02142","LU0634319403.HKD","KCE","IE0008369823.USD","LU2242644610.SGD","06160","LU0880133367.SGD","LU0417516738.SGD","LU0039217434.USD","LU0314109678.HKD","LU0348783233.USD","09995","01801","KURE","LU0051755006.USD","LU0348825331.USD","06185","LU1770034418.SGD","BK1589","159992","LU0516422952.EUR","LU0463099449.HKD","LU1969619763.USD","LU0359201612.USD","09926","LU0326950275.SGD","LU1794554557.SGD","SG9999002562.SGD","LU0516423091.SGD","LU1807302812.USD","161027","LNGR","LU1226287875.USD","LU0140636845.USD","LU0455707207.USD","LU1813983027.USD","SG9999004220.SGD","IE00BPRC5H50.USD","IBBQ","01877","06978","LU0307460666.USD","01177","01093","02269","09688","LU0348767384.USD","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662793180","title":"药明生物上半年营收118亿:同比增18% 净利29亿 市值2110亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662793180","media":"雷递网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662793180?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:11","pubTimestamp":1787728283,"startTime":"0","endTime":"0","summary":"药明生物技术有限公司(简称:“药明生物”,股份代号:2269)日前发布2026年上半年的财报。财报显示,药明生物2026年上半年营收为117.87亿,较上年同期的99.53亿增长18.4%。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260826/6392335386270481503875215.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260826/6392335386270481503875215.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34891/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662876136","title":"大行评级丨大摩:药明生物上半年业绩胜预期,目标价升至57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662876136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662876136?lang=zh_cn&edition=full","pubTime":"2026-08-26 10:42","pubTimestamp":1787712128,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999002463.SGD","LU0051755006.USD","LU0417516738.SGD","LU0708995583.HKD","LU0572944931.SGD","LU1242518931.SGD","LU0819121731.USD","LU0348735423.USD","LU0359202008.SGD","LU0516423091.SGD","KURE","LU0359201612.USD","LU0456846285.SGD","LU0823426308.USD","LU0856984785.SGD","LU1242518857.USD","LU0979878070.USD","LU0039217434.USD","LU0516422366.SGD","LU0516422952.EUR","LU0516422440.USD","LU0320764599.SGD","LU3063872942.SGD","LU0516423174.USD","SG9999002562.SGD","LU0588546209.SGD","LU1794554557.SGD","LU0128526141.USD","LU0181495838.USD","LU0140636845.USD","LU0307460666.USD","LU0456827905.SGD","LU2039709279.SGD","LU0043850808.USD","BK1141","BK1589","LU0417516902.SGD","LU0029874061.USD","02269","LU1720050803.USD","LU1688375341.USD","LU0052750758.USD","BK1610","BK1576","BK1521","LU0348825331.USD","LU1880383366.USD","IE00B0JY6N72.USD","LU0327786744.USD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140188750","title":"异动解读|药明生物盘中上涨4.02%,中期业绩强劲叠加上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1140188750","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140188750?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:30","pubTimestamp":1787707842,"startTime":"0","endTime":"0","summary":"8月26日,药明生物盘中上涨4.02%,报54.3港元,成交额2.15亿港元。消息面上,公司于8月25日发布中期业绩,上半年实现收益117.87亿元,同比增长18.4%;毛利54.48亿元,同比增长28.1%,毛利率由42.7%提升至46.2%;经调整归母净利润33.06亿元,同比大幅增长38.4%。公司同日上调全年业绩指引,三年内未完成订单约55亿美元,同比增长约30%,订单储备持续刷新纪录。业绩落地验证行业景气度上行,市场延续前一交易日积极反应。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物盘中上涨,中期业绩强劲上调指引","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662900734","title":"药明生物(02269.HK)上调全年业绩指引,持续高速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2662900734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662900734?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:09","pubTimestamp":1787659774,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","LU0052750758.USD","LU0979878070.USD","KURE","LU0043850808.USD","LU0572944931.SGD","02269","LU0588546209.SGD","LU1880383366.USD","LU0516423091.SGD","LU0181495838.USD","LU0708995583.HKD","LU1720050803.USD","LU0051755006.USD","BK1141","LU0320764599.SGD","LU1242518931.SGD","BK1521","BK1610","LU0029874061.USD","LU0516423174.USD","LU0516422440.USD","LU0456827905.SGD","LU0128526141.USD","LU1688375341.USD","LU0348825331.USD","LU0516422366.SGD","IE00B0JY6N72.USD","LU0417516902.SGD","LU0417516738.SGD","BK1589","LU0307460666.USD","LU0819121731.USD","LU0856984785.SGD","LU0140636845.USD","LU0359201612.USD","LU3063872942.SGD","LU0823426480.USD","LU2039709279.SGD","LU0348735423.USD","LU0359202008.SGD","LU1242518857.USD","LU0039217434.USD","SG9999002463.SGD","SG9999002562.SGD","LU0326950275.SGD","LU0456846285.SGD","LU1794554557.SGD","LU0823426308.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132507906","title":"药明生物(02269)披露2026年中期业绩:收入53.8亿元,同比增24.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132507906","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132507906?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:56","pubTimestamp":1787658981,"startTime":"0","endTime":"0","summary":"2026年8月25日,药明生物发布2026年中期业绩简报。报告期内,公司实现多项经营指标双位数增长,订单储备与项目数量继续刷新纪录。公司预计至2027年具备每年300个IND及20个BLA/MAA申报能力。三年内未完成订单约55亿美元,同比增长约30%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184581775","title":"药明生物中期净利达24.398亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1184581775","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184581775?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:06","pubTimestamp":1787652366,"startTime":"0","endTime":"0","summary":"8月25日,路透社消息——药明生物公布上半年业绩,归属于股东的净利润达到24.398亿元人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","LU3063872942.SGD","LU0029874061.USD","LU0708995583.HKD","LU1242518931.SGD","LU0128526141.USD","BK1141","LU0516423174.USD","LU0052750758.USD","LU0327786744.USD","LU0516423091.SGD","LU2039709279.SGD","LU0572944931.SGD","SG9999002463.SGD","LU0979878070.USD","LU0823426480.USD","LU0516422440.USD","LU1688375341.USD","LU1720050803.USD","LU0307460666.USD","LU0359201612.USD","LU0456827905.SGD","LU0819121731.USD","LU0588546209.SGD","LU0516422366.SGD","LU1880383366.USD","LU1794554557.SGD","BK1610","BK1576","SG9999002562.SGD","BK1589","LU0326950275.SGD","LU0417516738.SGD","LU0039217434.USD","LU1242518857.USD","LU0456846285.SGD","LU0856984785.SGD","LU0348735423.USD","LU0823426308.USD","LU0140636845.USD","LU0181495838.USD","LU0417516902.SGD","KURE","LU0051755006.USD","LU0359202008.SGD","LU0348825331.USD","LU0043850808.USD","LU0320764599.SGD","BK1521","IE00B0JY6N72.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733367","title":"药明生物(02269.HK)2026中期业绩强劲:收益118亿元,经调整归母净利同比增长38.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733367","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662733367?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:59","pubTimestamp":1787651942,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1242518857.USD","LU3063872942.SGD","LU0417516738.SGD","LU0588546209.SGD","LU0128526141.USD","LU0823426480.USD","LU0856984785.SGD","02269","LU2039709279.SGD","SG9999002463.SGD","LU0819121731.USD","LU0417516902.SGD","LU1880383366.USD","LU0307460666.USD","SG9999002562.SGD","LU0052750758.USD","BK1589","KURE","LU0320764599.SGD","LU1720050803.USD","BK1576","LU0456846285.SGD","LU1242518931.SGD","BK1521","LU0979878070.USD","LU0823426308.USD","LU0348735423.USD","LU0572944931.SGD","LU0516422440.USD","LU1794554557.SGD","LU0327786744.USD","LU0140636845.USD","LU0039217434.USD","LU0456827905.SGD","LU0181495838.USD","BK1141","LU0359201612.USD","LU0516422952.EUR","IE00B0JY6N72.USD","LU0516423091.SGD","LU0326950275.SGD","LU0051755006.USD","LU0043850808.USD","LU0348825331.USD","LU0359202008.SGD","LU0516423174.USD","LU0708995583.HKD","BK1610","LU1688375341.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738025","title":"药明生物(02269)发布中期业绩 公司拥有人应占纯利24.4亿元 同比增长4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738025","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738025?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:58","pubTimestamp":1787651917,"startTime":"0","endTime":"0","summary":"药明生物(02269)发布2026年中期业绩,该集团取得收益117.87亿元,同比增长18.4%;毛利54.48亿元,同比增长28.1%;公司拥有人应占纯利24.4亿元,同比增长4.3%;公司拥有人应占经调整纯利33.06亿元,同比增长38.4%;每股基本盈利0.6元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg46.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg46.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1576","LU0326950275.SGD","LU3063872942.SGD","LU1880383366.USD","LU0823426480.USD","BK1141","LU0819121731.USD","LU0029874061.USD","LU0320764599.SGD","LU0516422366.SGD","LU1688375341.USD","LU0516422440.USD","LU1794554557.SGD","BK1521","LU0181495838.USD","LU0327786744.USD","SG9999002463.SGD","LU0359202008.SGD","LU0456827905.SGD","BK1610","LU0128526141.USD","BK1589","LU0043850808.USD","LU0417516902.SGD","LU0516423091.SGD","LU0979878070.USD","LU1242518931.SGD","LU0856984785.SGD","LU0359201612.USD","LU1242518857.USD","LU0516423174.USD","LU0417516738.SGD","LU0456846285.SGD","LU0039217434.USD","LU0348825331.USD","LU0572944931.SGD","KURE","02269","LU0140636845.USD","IE00B0JY6N72.USD","LU0516422952.EUR","LU0052750758.USD","LU0708995583.HKD","LU2039709279.SGD","LU1720050803.USD","LU0823426308.USD","LU0588546209.SGD","LU0348735423.USD","SG9999002562.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114543838","title":"药明生物:上半年收益达117.87亿元,同比增长18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114543838","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114543838?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:58","pubTimestamp":1787651885,"startTime":"0","endTime":"0","summary":"8月25日,药明生物:上半年收益同比增长18.4%达人民币117.87亿元。毛利同比增长28.1%至人民币54.48亿元。纯利及本公司拥有人应占纯利分别同比增长5.8%及4.3%至人民币29.16亿元及人民币24.4亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物:上半年收益达117.87亿元,同比增长18.4%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127816707","title":"药明生物(02269)2026年中期营收增18.4%至117.87亿元 净利29.16亿元同比增5.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127816707","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127816707?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:56","pubTimestamp":1787651784,"startTime":"0","endTime":"0","summary":"8月25日,药明生物公布截至2026年6月30日止六个月业绩。期内,公司凭借“一体化端到端CRDMO平台”及“跟随并赢得分子”战略,实现收入117.87亿元,同比增长18.4%。同期毛利54.48亿元,增幅28.1%;毛利率由42.7%提升至46.2%。净利润29.16亿元,同比增长5.8%,净利率由27.7%降至24.7%。经调整后,归属于公司股东的净利润为33.06亿元,增幅38.4%;经调整净利率28.0%,高于上年同期的24.0%。基本每股收益人民币0.60元,同比增长3.4%;董事会决定不派发中期股息。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782834","title":"港股收评:恒指午后逆转跌幅几近收平,PCB与创新药爆发,黄金股全面回调","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782834","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662782834?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:17","pubTimestamp":1787645850,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0488056044.USD","LU0868486357.SGD","LU0196878994.USD","02269","LU0541501648.USD","LU1242518931.SGD","02268","LU0359202008.SGD","LU0307460666.USD","LU0683595622.HKD","IE00BPRC5H50.USD","07552","LU0871576103.HKD","BK1604","LU2399975544.HKD","LU0650527681.SGD","03067","LU0072462343.USD","LU0164880469.USD","LU1102505762.USD","LU1880383440.USD","LU0823040885.USD","LU0588545904.SGD","LU0251144936.SGD","LU0210526637.USD","LU0648948544.HKD","LU0588546209.SGD","LU0048580855.USD","LU0823426480.USD","LU2097828557.USD","LU0577902298.EUR","LU0269904917.USD","LU1328615791.USD","LU0449509016.USD","BK1147","LU0516423174.USD","KURE","LU0132412106.USD","KWEB","LU0918141705.HKD","LU2476274308.USD","LU0455707207.USD","LU0577902611.USD","LU0633140560.USD","LU0700851271.USD","LU0463099449.HKD","LU0449515922.USD","LU0611395673.USD","LU0049853897.USD","LU1961090484.USD","LU0516422366.SGD","LU0516423091.SGD","LU2039709279.SGD","LU2087589342.USD","BK1614","LU0143863198.USD","03033","LU0348814723.USD","FPA","IE00BF5LJ272.USD","LU0456827905.SGD","LU0315178854.USD","LU0231483743.USD","LU0594300419.USD","03037","LU1960683339.HKD","LU0051755006.USD","BK1142","03419","03115","LU0540923850.HKD","LU0149721374.USD","LU0543330483.HKD","LU0823041008.USD","LU1282648689.USD","LU1770034418.SGD","01888","LU1282649067.USD","LU2125910500.SGD","LU2476274720.SGD","IE0032431581.USD","IE0034224299.USD","LU0348827113.USD","LU0287142896.SGD","01548","HSTECH","SG9999002463.SGD","LU1048588211.SGD","LU0823426308.USD","MPNGY","LU0084288322.USD","LU2045819591.USD","BK1167","BK1589","LU0797268264.HKD","01912","LU0164865239.USD","LU0348825331.USD","LU1008478684.HKD","LU1720050803.USD","LU1688375341.USD","03417","07226","LU1880383366.USD","LU0327786744.USD","09088","LU0348735423.USD","LU0348788117.USD","09067","LU3063872942.SGD","LU0828237940.HKD","LU0823039010.USD","LU0577902371.SGD","LU0588545490.SGD","LU1734074674.USD","LU1868837722.USD","HSI","BK1521","BK1591","03690","LU1105468828.SGD","LU2187417386.USD","LU1807302812.USD","LU0345775950.USD","BK1583","LU0823038988.USD","LU1328277881.USD","SG9999000327.SGD","LU1152091168.USD","LU0261950983.USD","IE00B29SXG58.USD","02833","513600","LU2929501877.USD","LU1675838814.USD","LU0054450605.USD","LU0708995583.HKD","07300","LU1770036033.HKD","LU1808992512.USD","LU1303224171.USD","LU0326948709.USD","07200","07500","LU0588545730.USD","LU0561508036.HKD","LU0143863784.USD","SG9999001689.USD","LU0572944931.SGD","LU0326950275.SGD","SG9999000459.SGD","LU0067412154.USD","LU0047713382.USD","LU0128526141.USD","LU0244354667.USD","BK1615","LU0345776255.USD","LU0173614495.USD","LU0516422952.EUR","SG9999001903.USD","LU0737861699.HKD","HK0000320223.HKD","LU0164872284.USD","LU0594300179.USD","BK1575","LU0431992006.USD","LU0499858438.USD","LU2097828805.USD","LU0577902538.SGD","LU1323998911.USD","LU2242644610.SGD","BK1576","LU0029875118.USD","LU0417516902.SGD","LU1224709979.USD","LU0633140727.USD","LU1794554557.SGD","LU2097828714.EUR","LU0856984785.SGD","IE00B5MMRT66.SGD","LU2351347302.SGD","LU0828238088.HKD","LU2148510915.USD","MCHS","LU0011963245.USD","LU0359201885.HKD","LU1251922891.USD","SG9999002562.SGD","SG9999004220.SGD","IE00B031HY20.USD","LU0274383008.USD","LU0228659784.USD","LU0821914370.USD","LU2257852520.SGD","BK1618","LU0878005551.USD","LU1242518857.USD","LU0348816934.USD","LU0819123356.HKD","IE00B3M56506.USD","LU0819121731.USD","IE00B543WZ88.USD","03032","02837","LU0043850808.USD","LU0509642566.USD","LU0593848301.USD","LU0348805143.USD","LU0054237671.USD","LU0314109678.HKD","LU0516422440.USD","LU1993786604.SGD","LU1188198961.HKD","LU1719994722.HKD","IE0008369823.USD","SG9999002828.SGD","BK1610","LU1048596156.SGD","LU0140636845.USD","LU0541502299.USD","LU0880133367.SGD","LU0384037296.USD","LU1064130708.USD","BK1233","LU1226287529.USD","LU1481107354.HKD","LU2152927971.USD","82800","LU0117841782.USD","LU1813983027.USD","HK0000306685.HKD","03088","LU0048597586.USD","LU0106252389.USD","LU0605514214.HKD","LU0918141887.USD","LU0214875030.USD","09115","LU0417516738.SGD","MHImain","00188","LU0052750758.USD","LU0456846285.SGD","LU1211504680.USD","LU2097828631.EUR","LU0320764599.SGD","LU0672654166.SGD","LU1023057109.AUD","IE0008368742.USD","LU0370786039.SGD","LU0499858602.USD","LU0634319403.HKD","LU0873338254.USD","LU0165289439.USD","LU1064131003.USD","LU0589944569.HKD","LU0029874061.USD","MCHmain","LU1282649141.HKD","LU1868837565.USD","BK1170","IE00B0JY6N72.USD","HK0000306701.USD","LU0865486749.SGD","HMTD.SI","SG9999014674.SGD","WXXWY","LU2488822045.USD","LU1102505929.USD","LU2778985437.USD","HK0000320264.USD","BK1506","HHImain","LU0181495838.USD","LU0828237510.HKD","LU0072913022.USD","LU0211977185.USD","LU0502904849.HKD","LU2226246903.HKD","LU0039217434.USD","BK1141","METmain","LU1282649810.SGD","02800","LU0979878070.USD","03423","83115","LU0577902454.USD","LU0501845795.SGD","LU0359201612.USD","LU1868838027.USD","LU0320764755.SGD","LU1831875114.USD","LU1152091754.HKD","LU2097828474.EUR","LU0128522157.USD","LU0531971595.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662200439","title":"港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认","url":"https://stock-news.laohu8.com/highlight/detail?id=2662200439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662200439?lang=zh_cn&edition=full","pubTime":"2026-08-25 10:20","pubTimestamp":1787624451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516423091.SGD","IE00B0JY6N72.USD","LU0307460666.USD","LU0456827905.SGD","LU0029874061.USD","LU0417516738.SGD","LU3063872942.SGD","LU0516422440.USD","HK0000320264.USD","LU0572944931.SGD","LU1242518931.SGD","HK0000306685.HKD","LU0823426308.USD","LU0516423174.USD","KURE","LU2039709279.SGD","LU0043850808.USD","BK1610","BK1583","LU0516422366.SGD","LU0039217434.USD","02269","HK0000306701.USD","LU0052750758.USD","LU1242518857.USD","LU0348825331.USD","LU0417516902.SGD","LU0823426480.USD","LU0819121731.USD","LU1794554557.SGD","LU0456846285.SGD","BK1521","BK1141","BK1191","SG9999002463.SGD","LU0708995583.HKD","LU0326950275.SGD","LU0327786744.USD","LU0359202008.SGD","LU0140636845.USD","BK1589","LU0348735423.USD","01548","LU0979878070.USD","LU0516422952.EUR","LU1720050803.USD","06821","LU0128526141.USD","BK1576","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662004362","title":"港股异动 | CRO概念股涨幅居前 海外CXO业绩普遍超预期 机构指全球需求复苏确认","url":"https://stock-news.laohu8.com/highlight/detail?id=2662004362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662004362?lang=zh_cn&edition=full","pubTime":"2026-08-25 10:20","pubTimestamp":1787624451,"startTime":"0","endTime":"0","summary":"消息面上,IQVIA、Medpace、Lonza、三星生物等海外CXO龙头业绩密集披露,订单端强势反转,多家上调全年指引。湘财证券认为,近期CXO整体表现亮眼是全球医药融资回暖下产业基本面持续向好的全球性的趋势,中国CXO相关公司具备工程师红利将充分享受产业红利,在全球产业向好的趋势下持续性预计将较强。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0181495838.USD","06821","LU0456827905.SGD","LU0856984785.SGD","LU3063872942.SGD","LU0348825331.USD","LU0417516902.SGD","LU0516422952.EUR","BK4585","LU0516423174.USD","HK0000320223.HKD","BK1583","LU0140636845.USD","WX","LU1880383366.USD","LU0128526141.USD","LU0359201612.USD","LU1794554557.SGD","CXO","LU1688375341.USD","BK4588","HK0000320264.USD","LU0516422440.USD","KURE","01548","LU0327786744.USD","LU1242518931.SGD","LU2039709279.SGD","03347","BK1610","KCAI","LU0456846285.SGD","LU0051755006.USD","BK1141","LU0359202008.SGD","02269","LU0052750758.USD","LU1242518857.USD","LU0823426480.USD","LU0029874061.USD","LU0708995583.HKD","VXUS","LU0979878070.USD","LU0572944931.SGD","LU0417516738.SGD","LU0823426308.USD","BK1576","BK1521","LU0307460666.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.309},{"period":"3month","weight":0.5147},{"period":"6month","weight":0.2556},{"period":"1year","weight":0.5901},{"period":"ytd","weight":0.6062}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0101},{"period":"3month","weight":0.0152},{"period":"6month","weight":-0.04},{"period":"1year","weight":0.0144},{"period":"ytd","weight":-0.0025}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.555556,"avgChangeRate":0.002485},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061606},{"month":7,"riseRate":0.7,"avgChangeRate":0.085288},{"month":8,"riseRate":0.6,"avgChangeRate":0.057583},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}